Total Payments
$948.73
2024 Payments
$21.72
Companies
8
Transactions
70
Medicare Patients
254
Medicare Billing
$25,870
Payment Breakdown by Category
Food & Beverage$929.22 (97.9%)
Education$19.51 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $929.22 | 66 | 97.9% |
| Education | $19.51 | 4 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $342.88 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $262.87 | 19 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $159.70 | 11 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $86.24 | 6 | $0 (2018) |
| Genentech USA, Inc. | $33.53 | 2 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $25.48 | 2 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $20.91 | 1 | $0 (2019) |
| Gilead Sciences Inc | $17.12 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.72 | 1 | GlaxoSmithKline, LLC. ($21.72) |
| 2021 | $16.00 | 1 | GlaxoSmithKline, LLC. ($16.00) |
| 2020 | $161.83 | 15 | GlaxoSmithKline, LLC. ($119.14) |
| 2019 | $196.12 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($79.70) |
| 2018 | $80.44 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($62.52) |
| 2017 | $472.62 | 37 | GlaxoSmithKline, LLC. ($151.81) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2020 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Respiratory | ||||||
| 06/30/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2020 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Respiratory | ||||||
| 04/17/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: RESPIRATORY | ||||||
| 04/02/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: RESPIRATORY | ||||||
| 02/25/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: RESPIRATORY | ||||||
| 02/04/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: RESPIRATORY | ||||||
| 01/22/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: RESPIRATORY | ||||||
| 01/17/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiology | ||||||
| 11/26/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2019 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Respiratory | ||||||
| 09/04/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 54 | 71 | $24,970 | $6,214 |
| 2020 | 6 | 200 | 308 | $83,304 | $19,656 |
Total Patients
254
Total Services
379
Medicare Billing
$25,870
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 55 | $17,930 | $4,325 | 24.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 16 | $7,040 | $1,889 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 193 | $62,918 | $15,528 | 24.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 25 | 32 | $14,080 | $3,308 | 23.5% |
| 94375 | Diagnostic testing in a pulmonary function lab | Facility | 2020 | 22 | 24 | $1,704 | $288.48 | 16.9% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2020 | 19 | 20 | $1,520 | $201.00 | 13.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 17 | 17 | $926.00 | $166.60 | 18.0% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 21 | 22 | $2,156 | $164.76 | 7.6% |
About Dr. Henry Jackson, M.D
Dr. Henry Jackson, M.D is a Pulmonary Disease healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679549836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Jackson, M.D has received a total of $948.73 in payments from pharmaceutical and medical device companies, with $21.72 received in 2024. These payments were reported across 70 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($929.22).
As a Medicare-enrolled provider, Jackson has provided services to 254 Medicare beneficiaries, totaling 379 services with total Medicare billing of $25,870. Data is available for 2 years (2020–2021), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Metairie, LA
- Active Since 02/27/2006
- Last Updated 09/23/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1679549836
Products in Payments
- OFEV (Drug) $205.86
- TRELEGY ELLIPTA (Drug) $141.04
- ANORO (Drug) $72.90
- BEVESPI AEROSPHERE (Drug) $68.32
- LONHALA MAGNAIR (Drug) $65.23
- UTIBRON (Drug) $55.71
- STIOLTO (Drug) $41.84
- BROVANA (Drug) $38.76
- ANORO ELLIPTA (Drug) $33.62
- Esbriet (Biological) $33.53
- CINQAIR (Drug) $25.48
- UPTRAVI (Drug) $20.91
- SYMBICORT (Drug) $17.92
- BREO (Drug) $16.41
- STIOLTO RESPIMAT (Drug) $15.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Metairie
Dr. Samuel Seyler, M.d, M.D
Pulmonary Disease — Payments: $11,720
Pulmonary Disease $11,720
Thomas Nuttli, M.d, M.D
Pulmonary Disease — Payments: $9,219
Pulmonary Disease $9,219
Kenneth Smith, M.d, M.D
Pulmonary Disease — Payments: $6,525
Pulmonary Disease $6,525
Dr. Enrique Diaz Guzman Zavala, M.d, M.D
Pulmonary Disease — Payments: $5,871
Pulmonary Disease $5,871
James Mccullough, M.d, M.D
Pulmonary Disease — Payments: $5,014
Pulmonary Disease $5,014
Brooks Culotta, Md, MD
Pulmonary Disease — Payments: $808.00
Pulmonary Disease $808.00